argenx SE retains a Hold rating due to valuation constraints and pipeline setbacks, despite strong commercial execution with VYVGART. Recent termination of TED and lupus nephritis programs narrows ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results